Jeksar 40 Tablet contains Telmisartan 40mg, an angiotensin II receptor antagonist primarily indicated for the management of hypertension. By selectively blocking the binding of angiotensin II to the AT1 receptor, Telmisartan effectively reduces vasoconstriction and aldosterone secretion, resulting in decreased peripheral vascular resistance and lowered blood pressure. This antihypertensive action helps reduce the risk of cardiovascular events such as stroke, myocardial infarction, and heart failure in patients with elevated blood pressure. Jeksar 40 is also utilized in the treatment of patients with left ventricular hypertrophy to reduce cardiovascular morbidity. The tablet is generally well tolerated, with common side effects including dizziness, headache, and fatigue. It is contraindicated in patients with hypersensitivity to Telmisartan or any tablet components, and caution is advised in patients with impaired renal or hepatic function. Jeksar 40 should be administered under medical supervision, with dosage adjustments based on therapeutic response and patient tolerance. Regular monitoring of blood pressure, renal function, and electrolytes is recommended during treatment. This medication is not indicated for use during pregnancy due to potential fetal toxicity. Jeksar 40 Tablet offers an effective option for blood pressure control within a comprehensive cardiovascular risk management plan.